亏损及研发致现金流出

港股IPO招股书披露先例 · 71 家公司,71 项

亏损及研发所致经营活动现金流出指申请人因除税前亏损以及研发、临床试验、商业化或行政等开支较大,导致经营活动现金净流出的情形。该事项一般于风险因素、业务、财务资料及概要等章节披露,申请人通常列示各期间现金流出净额及其主要成因,说明以股东注资、私募融资或全球发售所得款项满足营运资金需求,并提出加强应收款催收、成本管控等改善措施,董事亦常确认未来十二个月营运资金充足。

2026-05-29Application Proof
浙江力积存储科技股份有限公司Zhejiang Zentel Memory Technology Co., Ltd.

经营活动现金流连续三年净流出

We recorded net cash outflows from operating activities in 2023, 2024 and 2025, amounting to RMB62.9 million, RMB18.2 million and RMB192.1 million, respectively, mainly due to our loss before tax amounting to RMB245.2 million, RMB109.8 million and RMB11.1 million in the respective years.

Summary · 第 7 页

We plan to improve our net operating cash outflows position by (i) enhancing inventory management, and (ii) optimizing our receivables and payables.

Summary · 第 7 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-28Prospectus
天辰生物医药(苏州)股份有限公司LongBio Pharma (Suzhou) Co., Ltd.01779.HK

经营活动现金持续净流出

We recorded net cash flows used in operating activities of RMB104.1 million and RMB121.0 million for the years ended December 31, 2024 and 2025, respectively.

Financial Information · 第 241 页

During the Track Record Period and up to the Latest Practicable Date, we have primarily funded our working capital requirements through equity financing and debt financing.

Financial Information · 第 241 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-28Application Proof
麓鹏制药有限公司Lupeng Pharmaceutical Ltd.

经营活动所用现金净额持续为负

During the Track Record Period, we incurred negative cash flows from our operations and substantially all of our operating cash outflows resulted from our R&D and administrative activities.

Financial Information · 第 238 页

We expect to generate more cash flow from our operating activities through the launch and commercialization of our products, enhanced cost containment capacity and operating efficiency, as well as potentially from collaboration and/or licensing arrangements.

Financial Information · 第 238 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-28Application Proof
苏州天瞳威视电子科技股份有限公司Suzhou Calmcar Electronics Technology Co., Limited

往绩期间经营活动现金净流出

(iii) notwithstanding the operating losses and net cash operating outflows during the years ended December 31, 2023, 2024 and 2025, the expected commercialization and revenue growth prospects did not indicate impairment

Financial Information · 第 199 页

However, we expect our net operating cash flow to turn positive in 2026, primarily driven by the collection of a substantial portion of our outstanding trade receivables, resulting in an overall improvement in our cash flow position.

Summary · 第 16 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-27Application Proof
科望医药集团Elpiscience Biopharmaceuticals, Inc.

2025年经营活动现金净流出1.36亿元

We recorded net cash used in operating activities of RMB136.1 million for the year ended December 31, 2025. For the year ended December 31, 2024, we generated net cash from operating activities of RMB2.7 million, which was primarily derived from our collaboration, option and license agreement with Astellas.

Financial Information · 第 254 页

During the Track Record Period, we funded our operation primarily through bank borrowings and proceeds from equity financing.

Financial Information · 第 254 页

We currently do not have unutilized banking facilities but may negotiate with financial institutions to secure additional credit lines or financing options based on our future operational needs.

Financial Information · 第 254 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-14Application Proof
安序源科技Axbio International Limited

经营活动现金净流出每年逾1,400万美元

We recorded net cash used in operating activities of US$15.0 million and US$14.3 million in 2024 and 2025, respectively.

Financial Information · 第 238 页

Our primary use of cash during the Track Record Period was to fund our research and development activities.

Financial Information · 第 238 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-05Prospectus
剂泰科技(北京)股份有限公司Metis TechBio Co., Ltd.07666.HK

往绩记录期间经营活动现金净流出

We recorded net cash used in operating activities of RMB192.4 million, RMB239.2 million and RMB121.6 million in 2023, 2024 and 2025, respectively.

Business · 第 187 页

Our increased net cash used in operating activities during the Track Record Period was primarily due to our net loss position and the increased operating expenses, reflecting the continuous upgrade and innovation of our technological capabilities and our rapid business expansion.

Business · 第 187 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-04-30Prospectus
深圳乐动机器人股份有限公司SHENZHEN LDROBOT CO., LTD01236.HK

往绩记录期间经营活动现金净流出

In 2025, we had net cash used in operating activities of RMB136.5 million, which represents our loss before tax of RMB62.5 million, adjusted for certain non-cash and non-operating items, primarily including (i) share-based payment compensation of RMB22.8 million, (ii) depreciation of property, plant and equipment of RMB8.8 million, and (iii) depreciation of right-of-use assets of RMB7.5 million.

Summary · 第 11 页

In 2023, we had net cash used in operating activities of RMB49.1 million, which represents our loss before tax of RMB68.5 million, adjusted for certain non-cash and non-operating items, primarily including (i) share-based payment compensation of RMB12.7 million, (ii) investment income from certificate of deposits of RMB7.0 million, (iii) depreciation of right-of use assets of RMB5.6 million, and (iv) depreciation of property, plant and equipment of RMB5.1 million.

Summary · 第 12 页

Our net cash flow used in operating activities during the Track Record Period was primarily due to our loss before taxes and the continued increase in trade and bill receivables.

Financial Information · 第 239 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-04-20Prospectus
上海曦智科技股份有限公司Shanghai Xizhi Technology Co., Ltd.01879.HK

经营活动现金净流出预计持续

We recorded adjusted net loss (non-IFRS measure) and net operating cash outflow during the Track Record Period, and we currently anticipate that these positions may persist until we achieve full-scale commercialization of both our optical interconnect business, and our optical computing business.

Business · 第 183 页

During the Track Record Period, we funded our cash requirements primarily through capital contributions from shareholders and financing activities, including issuances of convertible preferred shares, convertible bond and financial instruments issued to investors with preference rights.

Business · 第 183 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-04-01Application Proof

往绩记录期间经营活动现金持续净流出

During the Track Record Period, we recorded net cash used in operating activities of RMB471.8 million, RMB174.1 million and RMB203.5 million in 2023, 2024 and 2025, respectively.

Summary · 第 9 页

During the Track Record Period, we recorded net cash flows used in operating activities of RMB471.8 million, RMB174.1 million and RMB203.5 million in 2023, 2024 and 2025, respectively, primarily due to our net loss position and changes in working capital during the relevant periods.

Business · 第 151 页

We plan to improve our net operating cash flow position through the following: (i) driving revenue growth and improving profitability through implementation of the above business strategies, thereby narrowing operating losses; and (ii) strengthening working capital management, including improving collection efficiency, prudently managing inventory levels and allocating financial resources appropriately.

Business · 第 151 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-03-29Application Proof

2025年经营活动现金净流出7,340万元

We recorded net operating cash outflows of RMB73.4 million in 2025 primarily due to (i) our decreased operating income, mainly attributable to (a) increased research and development expenses as we expanded our research and development workforce to support our research and development initiatives; and (b) the [REDACTED] expenses incurred in 2025; and (ii) the impact of working capital changes, mainly attributable to (a) decreased trade and bills payables as the impact of certain credit term extensions in 2024 gradually phased out and we discontinued the stockpiling strategy in 2025; and (b) increased restricted cash related to discounted bills payables.

Financial Information · 第 239 页

Taking into consideration the financial resources available to us, including our cash and cash equivalents on hand of RMB476.7 million and time deposits of RMB54.2 million as of December 31, 2025 as well as our unutilized banking facilities of RMB570.0 million as of the same date, our operating cash flows and the estimated [REDACTED] from the [REDACTED], in the absence of unforeseeable circumstances, the Directors confirm, and the Sole Sponsor concurs, that we have sufficient working capital to meet our present requirements and for at least the next 12 months from the date of this document.

Financial Information · 第 239 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-03-23Application Proof
杭州先为达生物科技股份有限公司Hangzhou Sciwind Biosciences Co., Ltd.

2025年经营活动现金净流出1.856亿元

During the Track Record Period, we incurred positive operating cashflow of RMB99.3 million in 2024, and negative operating cashflow of RMB185.6 million in 2025.

Financial Information · 第 259 页

As of December 31, 2025, we had RMB839.1 million of cash and cash equivalents.

Financial Information · 第 259 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-03-20Application Proof
杭州新元素药业股份有限公司Atom Therapeutics Co., Ltd.

经营活动现金净流出3.684亿及1.19亿元

In 2024 and 2025, we recorded net cash used in operating activities of RMB368.4 million and RMB119.0 million, respectively.

Financial Information · 第 257 页

We expect to generate more cash flow from our operating activities, through launching and commercializing our products, enhancing our cost containment capacity and operating efficiency, as well as potentially from collaboration and/or licensing arrangements.

Financial Information · 第 257 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-03-18Application Proof

往绩记录期间经营活动现金净流出

We experienced negative operating cash flows during the Track Record Period.

Financial Information · 第 260 页

We have historically financed our operations primarily through cash generated from financing activities.

Financial Information · 第 260 页

Based on our available cash and cash equivalents, and despite the net operating cash outflows during the Track Record Period, we believe our cash balance is sufficient to meet our operating needs and support our planned expansion.

Financial Information · 第 260 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-03-16Prospectus
浙江凯乐士科技集团股份有限公司Zhejiang Galaxis Technology Group Co., Ltd.02729.HK

往绩记录期间经营活动现金净流出

We recorded net losses and experienced net operating cash outflows during the Track Record Period, and we anticipate continuing this trend into 2026, primarily due to being in a growth phase with significant investments in research and development, market expansion, and new product development.

Summary · 第 16 页

Leveraging our strong market position in four-way MSR and VFR products, where we maintain significant market share and customer recognition, we have successfully negotiated improved payment structures.

Financial Information · 第 237 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-01-30Prospectus
爱芯元智半导体股份有限公司Axera Semiconductor Co., Ltd.00600.HK

经营活动现金净流出持续

We had net operating cash outflow of RMB447.4 million, RMB460.2 million, RMB597.5 million and RMB548.9 million in 2022, 2023, 2024 and the nine months ended September 30, 2025, respectively.

Financial Information · 第 303 页

We expect to improve our net current liabilities position and net operating cash outflow position primarily through (i) capturing the opportunities presented by the fast-growing markets; (ii) enriching our product portfolio and expanding our customer base; (iii) optimizing business mix to maintain and improve our gross margin profile; (iv) enhancing our operational efficiency and economies of scale; and (v) continuing stringent cash management practices.

Financial Information · 第 303 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-12-31Prospectus

经营活动现金流出随研发投入扩大

Our cash burn increased throughout the Track Record Period primarily due to increases in net cash used in operating activities as we scale up R&D activities.

Financial Information · 第 447 页

Our accumulated losses, adjusted net losses (non-IFRS measure) and net operating cash outflows were primarily due to the significant amounts of research and development expenses incurred during the Track Record Period while our commercialization of model was at nascent stage.

Business · 第 310 页

During the Track Record Period, we funded our cash requirements primarily through capital contributions from shareholders and financing activities, including issuances of convertible redeemable preferred shares and convertible bonds.

Business · 第 310 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-12-30Prospectus
北京智谱华章科技股份有限公司Knowledge Atlas Technology Joint Stock Company Limited02513.HK

经营活动现金流出净额逐年扩大

We had net cash flows used in operating activities of RMB68.2 million, RMB648.0 million, RMB2,244.9 million, RMB994.7 million and RMB1,327.2 million in 2022, 2023, 2024 and the six months ended June 30, 2024 and 2025, respectively.

Business · 第 202 页

Our operating cash flows were primarily due to (i) our net losses and (ii) our significant investments in our research and development efforts to enhance our services during the Track Record Period.

Business · 第 202 页

We expect to improve our net operating cash outflows position by taking advantage of (i) our continuous revenue growth; (ii) our improved operating leverage; and (iii) our improved working capital.

Business · 第 202 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us